Dear friends and colleagues,
We are delighted to bring you the latest quarterly newsletter from the International Centre for Antimicrobial Resistance Solutions (ICARS).
Over the past few months, ICARS has been actively involved in conferences, visits, and new partnership initiatives, engaging in discussions about antimicrobial resistance (AMR) on a global scale.
The last quarter brought forth several significant milestones:
ICARS signed a Memorandum of Understanding (MoU) with the Health Ministry of the Lao People’s Democratic Republic, marking the launch of our first project in the country. Concurrently, we solidified our strategic collaboration with Pakistan, which also joined us as a mission partner, by signing two MoUs aimed at addressing antimicrobial misuse.
During this period, a team from an ICARS-supported project in Kyrgyzstan presented promising results from their research into the appropriate use of antibiotics for respiratory tract infections in children during their visit to ICARS headquarters in Copenhagen.
ICARS advisors also had the opportunity to visit an FAO's Farmer Field School in Zimbabwe to gain insights into its operations and explore potential applications to ICARS projects.
In late summer, ICARS partnered with ReAct Africa and South Centre to co-host the Antimicrobial Resistance Conference in Lusaka, Zambia, which served as a platform for engaging in discussions on the development and implementation of National Action Plans (NAPs) on AMR.
Are you interested in ICARS' approach? We recently released our latest policy brief, which delineates our strategy for addressing AMR in LMICs, illustrated by examples drawn from our project portfolio.
Additionally, ICARS took part in the World Congress on Antimicrobial Resistance in Philadelphia, presenting and engaging with a range of stakeholders and sharing our experience mitigating AMR in Low- and Middle-Income Countries (LMICs).
Further strengthening our engagement, ICARS' Executive Director, Dr. Sujith J. Chandy, contributed to the African Regional Workshop in Dakar, Senegal, sharing experiences from ICARS projects.
Lastly, ICARS had the pleasure of hosting visits from the Centre for Cellular and Molecular Platforms (C-Camp) and the International Vaccine Institute (IVI) to discuss opportunities for closer collaborations and partnerships to mitigate AMR in LMICs.
We would like to express our gratitude for your continued interest in ICARS and our mission. For weekly updates, recommended readings, and information on upcoming events, consider following us on social media.
Thank you for your ongoing support!
Best wishes,
The ICARS Team
Looking for AMR resources?
We recently launched the ICARS Knowledge Hub on our website, where you can find a collection of outputs from the ICARS team and our partners.
Interested in working with ICARS?
Our upcoming deadline for submitting Expressions of Interest is October 15th. Accepted proposals will undergo co-development throughout 2024.
